Non-HDL Cholesterol
| Clinical | Optimal | |
|---|---|---|
| Male | 0.0 - 5.2 mmol/L | <4.0 mmol/L (ideal <2.5 mmol/L for high-risk individuals) |
| Female | 0.0 - 5.2 mmol/L | <4.0 mmol/L (ideal <2.5 mmol/L for high-risk individuals) |
What is Non-HDL Cholesterol?
Non-HDL cholesterol is calculated by subtracting HDL (high-density lipoprotein) cholesterol from total cholesterol. The resulting figure captures all the 'bad' cholesterol-carrying particles in your blood, including LDL, VLDL, IDL, and lipoprotein(a). This makes it a more comprehensive measure of cardiovascular risk than LDL cholesterol alone.
Unlike LDL, which only measures one type of atherogenic particle, non-HDL cholesterol accounts for all lipoproteins that can deposit cholesterol in artery walls and contribute to plaque formation. This is particularly important because some individuals may have normal LDL but elevated VLDL or remnant cholesterol, which would only be captured by non-HDL measurement.
Non-HDL cholesterol has been adopted by NICE as the preferred lipid target for cardiovascular risk assessment in the UK, reflecting its superior predictive value compared to LDL cholesterol alone.
Why Non-HDL Cholesterol Matters for Your Health
Cardiovascular disease remains the leading cause of death globally, and non-HDL cholesterol is one of the strongest modifiable risk factors. Every 1 mmol/L reduction in non-HDL cholesterol is associated with a significant decrease in cardiovascular events over time.
For longevity-focused individuals, optimising non-HDL cholesterol is one of the most impactful interventions available. Atherosclerosis begins decades before symptoms appear, and cumulative lifetime exposure to atherogenic lipoproteins is a key driver of plaque development.
Non-HDL cholesterol is particularly valuable because it can be measured in a non-fasting state without significantly affecting accuracy. This makes it more practical for routine monitoring and provides a reliable snapshot of your cardiovascular risk at any time of day.
Non-HDL Cholesterol& Your Wearable Data
Non-HDL cholesterol represents all atherogenic (artery-damaging) cholesterol and is calculated by subtracting HDL from total cholesterol. Many clinicians consider it a better risk predictor than LDL alone because it includes VLDL and other harmful particles. Wearable cardiovascular data provides excellent complementary risk assessment alongside non-HDL cholesterol.
Regular exercise tracked by your wearable is one of the most effective ways to lower non-HDL cholesterol. Achieving 150+ minutes of moderate-intensity exercise per week, visible in your heart rate zone data, reduces non-HDL by lowering triglyceride-rich lipoproteins. Your wearable's weekly activity summaries help ensure you are meeting the exercise thresholds that benefit lipid profiles.
VO2 max estimated by your wearable is an independent predictor of cardiovascular risk, complementing non-HDL cholesterol for risk stratification. Combining wearable fitness metrics with blood lipid data gives a more accurate cardiovascular risk picture than either alone. Improving VO2 max through progressive training simultaneously lowers non-HDL cholesterol and overall cardiovascular risk.
What High Non-HDL Cholesterol May Suggest
Elevated non-HDL cholesterol suggests an increased burden of atherogenic particles in the bloodstream, which raises the risk of coronary artery disease, stroke, and peripheral vascular disease. Common causes include a diet high in saturated fat, genetic predisposition (familial hypercholesterolaemia), obesity, type 2 diabetes, hypothyroidism, and kidney disease.
High non-HDL cholesterol is often asymptomatic until significant arterial damage has occurred. This is why regular monitoring is so valuable — it allows for early intervention before clinical disease develops.
If results suggest elevated non-HDL cholesterol, a comprehensive approach combining dietary changes, lifestyle modifications, and medical review is recommended. Your GP may assess your overall cardiovascular risk using tools such as QRISK3 to determine the most appropriate management strategy.
What Low Non-HDL Cholesterol May Suggest
Low non-HDL cholesterol is generally considered favourable for cardiovascular health. Very low levels (below 1.5 mmol/L) are uncommon and may be seen in individuals with malabsorption conditions, hyperthyroidism, liver disease, or malnutrition.
Some research has explored whether extremely low cholesterol levels might be associated with increased risk of certain conditions, including haemorrhagic stroke or mood disorders, though the evidence remains inconclusive and the benefits of lower non-HDL cholesterol for cardiovascular health are well established.
If results suggest unexpectedly low non-HDL cholesterol without dietary or lifestyle explanation, your GP may wish to investigate thyroid and liver function.
How to Optimise Your Non-HDL Cholesterol
Food
Reduce saturated fat intake by swapping butter for olive oil, choosing lean proteins, and limiting processed meats and full-fat dairy. Increase soluble fibre from oats, barley, beans, lentils, and fruit, which binds cholesterol in the gut and aids its removal. Include plant sterols and stanols from fortified foods or naturally from nuts, seeds, and legumes. Eat oily fish (salmon, mackerel, sardines) at least twice weekly for omega-3 fatty acids. Add a handful of almonds or walnuts daily, as tree nuts have been shown to lower non-HDL cholesterol.
Lifestyle
Engage in at least 150 minutes of moderate aerobic exercise per week, which can raise HDL and lower atherogenic particles. Achieve and maintain a healthy weight, as even modest weight loss of 5–10% can significantly improve lipid profiles. Stop smoking, as tobacco use lowers protective HDL and promotes arterial damage. Limit alcohol intake to within UK guidelines (14 units per week maximum). Manage stress effectively, as chronic stress hormones can adversely affect cholesterol metabolism.
Supplements
Plant sterol supplements (2g daily) can lower LDL cholesterol by approximately 10% and are endorsed by the European Atherosclerosis Society. Bergamot polyphenol extract has emerging evidence for supporting healthy lipid metabolism. Omega-3 fish oil (EPA/DHA) at therapeutic doses may help lower triglyceride-rich particles that contribute to non-HDL cholesterol.
When to Speak to Your GP
See your GP if non-HDL cholesterol exceeds 4.0 mmol/L, particularly if you have additional cardiovascular risk factors such as high blood pressure, diabetes, smoking, or a family history of premature heart disease. If non-HDL cholesterol is above 5.0 mmol/L, screening for familial hypercholesterolaemia should be considered. Regular monitoring is recommended for anyone with a QRISK3 score above 10%.
References
- NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. CG181. nice.org.uk
- NHS. High cholesterol — Overview. Updated 2024. nhs.uk
- ESC. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188. pubmed.ncbi.nlm.nih.gov
- BMJ. Brunner FJ, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification. Eur Heart J. 2019;40(25):2006-2014. pubmed.ncbi.nlm.nih.gov
Medical Disclaimer— This content is for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Omniwo Ltd is a wellness information service and is not a medical device, clinical laboratory, or regulated healthcare provider under MHRA guidelines. The “optimal ranges” presented on this page are based on published clinical guidelines (WHO, NICE, NHS) and peer-reviewed research; they represent functional wellness targets and may differ from standard laboratory reference ranges. Individual results should always be interpreted by a qualified healthcare professional (such as your GP) who understands your full medical history. Do not start, stop, or change any medication or supplement based solely on this information. If you are experiencing symptoms, seek medical attention promptly.